GLP-1 influences PD pathogenesis via its G protein-coupled receptor, which activates both cAMP-PKA pathways and PI3Ks pathways acting via Akt, PKC, and MAPK (Fig. 1b). This evidence concerns the gene AKT1 and Parkinson disease.